Regeneration and the mechanism of epidermal tumor promotion
- 1 January 1985
- journal article
- review article
- Published by Taylor & Francis in CRC Critical Reviews in Toxicology
- Vol. 14 (3) , 211-258
- https://doi.org/10.3109/10408448509037459
Abstract
Chemically induced epidermal carcinogenesis is often divided into two stages: initiation, which involves the conversion of some epidermal cells into latent neoplastic cells, and promotion, which allows the evolution of this neoplastic change into the formation of a neoplasm. The hallmark of epidermal tumor promotion is the transformation of the normal epidermis into a hyperplastic epidermis. A major unanswered question about epidermal tumor promotion is whether the epidermal hyperplasia that characterizes promoted skin is a regenerative epidermal hyperplasia resulting from damage produced by the promoter. The opinion currently held is that the epidermal hyperplasia produced by tumor promoters is not simply a regenerative epidermal hyperplasia and possesses characteristics which a regenerative hyperplasia does not have, enabling it to evolve into an epidermal neoplasm. The purpose of this review is to present recent evidence which strongly suggests that promoter-induced epidermal hyperplasia is a regenerative hyperplasia. Three principal lines of evidence are reviewed. The first demonstrates that an epidermal regenerative hyperplasia repeatedly produced by wounding or abrasion can promote epidermal carcinogenesis in the initiated skin of mice. The second line of evidence demonstrates that the epidermal hyperplasia produced by the application of 12-O-tetradecanoyl-phorbol-13-acetate (TPA), the most powerful and widely used promoter of skin carcinogenesis, is preceded by damage to the epidermis. This strongly suggests that the epidermal hyperplasia which ensues is a regenerative hyperplasia. Thirdly, evidence is presented which demonstrates that hyperplasia-producing agents which do not promote, produce an epidermal hyperplasia which is different from that produced by tumor promoters. Finally, the review discusses the evidence which suggests that the production of a hyperplasia may be the mechanism for tumor promotion in other organs, such as the liver, bladder, and intestine.Keywords
This publication has 110 references indexed in Scilit:
- An inhibitory effect of tumour promoters on human epithelial cell growth can be dissociated from an effect on junctional communicationExperimental Cell Research, 1983
- Stimulated Human Phagocytes Produce Cytogenetic Changes in Cultured Mammalian CellsNew England Journal of Medicine, 1983
- Chemical CarcinogenesisNew England Journal of Medicine, 1981
- Effects of the tumor promoter 12-O-tetradecanoyl-phorbol-13-acetate on newly synthesized proteins in mouse epidermisCell, 1981
- Synergistic effects of epidermal growth factor and thrombin on the growth stimulation of diploid chinese hamster fibroblastsJournal of Cellular Physiology, 1980
- Indomethacin inhibition of cell proliferation induced by the phorbolester TPA is reversed by prostaglandin E2 in mouse epidermis in vivoBiochemical and Biophysical Research Communications, 1978
- Cutaneous Chemical Carcinogenesis: Past, Present, And FutureJournal of Investigative Dermatology, 1976
- Some mechanisms operative in carcinogenesis a reviewChemico-Biological Interactions, 1976
- STUDIES ON THE CONSERVATION OF EPIDERMAL SPECIFICITIES OF SKIN AND CERTAIN MUCOSAS IN ADULT MAMMALSThe Journal of Experimental Medicine, 1967
- THE PART PLAYED BY INJURY AND REPAIR IN THE DEVELOPMENT OF CANCERBMJ, 1927